Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)
0.9492
-0.0008
(-0.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 21, 2026
Add to My Watchlist
Press Releases about Lexaria Bioscience Corp. - Common Stock
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
April 07, 2026
Lexaria to Begin New Human Clinical Study in GLP-1
April 01, 2026
Lexaria's Robust Patent Portfolio Continues to Grow
March 26, 2026
Lexaria Attending BIO International Convention
June 05, 2025
Lexaria's Oral GLP-1 Drug Strategy Validated by Industry
March 24, 2026
Lexaria Announces New R&D Plans for 2026
March 04, 2026
Lexaria Announces Positive Final Results From Human Pilot Study #5
February 05, 2026
Lexaria Awarded Six Additional Patents
January 22, 2026
Lexaria Releases Annual Letter from the CEO
January 12, 2026
Lexaria Bioscience Corp. Provides Strategic Update
October 09, 2025
GLP-1 "Arms Race" Broadens to Include Dozens of Companies
August 06, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.